Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2001

01-11-2001

Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor β2 expression in breast carcinoma

Authors: Qifeng Yang, Goro Yoshimura, Takeo Sakurai, Misa Nakamura, Yasushi Nakamura, Liang Shan, Takaomi Suzuma, Takeshi Tamaki, Teiji Umemura, Ichiro Mori, Kennichi Kakudo

Published in: Breast Cancer Research and Treatment | Issue 1/2001

Login to get access
Metadata
Title
Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor β2 expression in breast carcinoma
Authors
Qifeng Yang
Goro Yoshimura
Takeo Sakurai
Misa Nakamura
Yasushi Nakamura
Liang Shan
Takaomi Suzuma
Takeshi Tamaki
Teiji Umemura
Ichiro Mori
Kennichi Kakudo
Publication date
01-11-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1012574305832

Other articles of this Issue 1/2001

Breast Cancer Research and Treatment 1/2001 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine